EUVIMEDEUVIMED entdecken
Crossref

Evaluation of a Novel MAGEC1 Variant and Susceptibility to Ovarian Cancer in the North Indian Population

Minerva Sharma, Sonali Verma, Vanshika Bhagat, Ziya Tufail, Rajeshwer Singh Jamwal, Bhawani Sharma, Gresh Chander, Ruchi Shah, Audesh Bhat, Manushi Dhar, Supinder Singh, Rakesh Kumar iD

Genetic Testing and Molecular Biomarkers · 2025

DOI: 10.1089/gtmb.2025.0029 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genetic Testing and Molecular Biomarkers, 2025. Verfasst von Minerva Sharma und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Biotechnology, Shri Mata Vaishno Devi University, Katra, India. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Antigens, Neoplasm, Neoplasm Proteins. Die Arbeit nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To check the correlation between the MAGE Family Member C1 (MAGEC1) gene variant rs176036 and ovarian cancer risk among the Jammu and Kashmir population. Methodology: A case-control association study of the MAGEC1 gene variant rs176036 (G > A) and ovarian cancer. The variation was identified through whole exome sequencing, and the selected variant was genotyped in 111 patients with ovarian cancer and 107 healthy controls belonging to the Jammu and Kashmir region of North India using Sanger sequencing to confirm its association with the ovarian cancer. Odds ratio (OR) and other statistical values were calculated using standard tools.

Results

The allelic frequency distribution was found to be similar between cases and controls, with the dominant allele (G) present in 89.6% of cases and 90.2% of controls (p = 0.84). The allelic OR for the dominant allele was 1.08 (0.55-2.11), which is nonsignificant (p = 0.83).

Conclusion

The present study suggests that the rs176036 variant does not confer any increased risk of ovarian cancer among population of Jammu and Kashmir.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ovarian NeoplasmsAntigens, NeoplasmNeoplasm ProteinsHumansFemaleIndiaGenetic Predisposition to DiseaseCase-Control StudiesMiddle AgedGene FrequencyPolymorphism, Single NucleotideAdultAllelesGenotypeAgedOdds Ratio

Stichwörter der Autor:innen

Jammu and KashmirMAGEC1Sanger sequencing

Substanzen

Antigens, NeoplasmNeoplasm Proteins

Autor:innen und Institutionen

  • School of Biotechnology, Shri Mata Vaishno Devi University, Katra, India.
  • Indian Council of Medical Research-Centre for Advance Research, Shri Mata Vaishno Devi University, Katra, India.
  • Centre for Molecular Biology, Central University of Jammu, Jammu & Kashmir, India.
  • Department of Biological Sciences, Indian Institute of Science Education and Research Bhopal, Bhopal, India.
  • Department of Medicine, ASCOMS, Jammu, India.

ORCID-Profile: Rakesh Kumar

Zitieren

APA

Sharma, M., Verma, S., Bhagat, V., Tufail, Z., Jamwal, R. S., Sharma, B., Chander, G., Shah, R., Bhat, A., Dhar, M., Singh, S., & Kumar, R. (2025). Evaluation of a Novel MAGEC1 Variant and Susceptibility to Ovarian Cancer in the North Indian Population. Genetic Testing and Molecular Biomarkers. https://doi.org/10.1089/gtmb.2025.0029

Vancouver

Sharma M, Verma S, Bhagat V, Tufail Z, Jamwal RS, Sharma B, et al. Evaluation of a Novel MAGEC1 Variant and Susceptibility to Ovarian Cancer in the North Indian Population. Genetic Testing and Molecular Biomarkers. 2025. doi:10.1089/gtmb.2025.0029

BibTeX
@article{Sharma2025,
  author = {Sharma, Minerva and Verma, Sonali and Bhagat, Vanshika and Tufail, Ziya and Jamwal, Rajeshwer Singh and Sharma, Bhawani and Chander, Gresh and Shah, Ruchi and Bhat, Audesh and Dhar, Manushi and Singh, Supinder and Kumar, Rakesh},
  title = {Evaluation of a Novel MAGEC1 Variant and Susceptibility to Ovarian Cancer in the North Indian Population},
  journal = {Genetic Testing and Molecular Biomarkers},
  year = {2025},
  doi = {10.1089/gtmb.2025.0029}
}
Kostenlos starten →